Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,259.50
-11.10 (-0.34%)
Oct 23, 2026, 11:20 AM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 407.23 billion as of October 22, 2026. It is the 3,991st most valuable company in the world and the 226th biggest in India. Its market cap has increased by 33.22% in one year.
Market Cap
407.23B
Enterprise Value
403.26B
Revenue
57.76B
Global Rank
Country Rank
#226 India
PE Ratio
35.89
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 407.23B, an increase of 71,874.33%. That is a compound annual growth rate of 30.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 407.23B | 17.76% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.07T |
| Aurobindo Pharma | 932.92B |
| Mankind Pharma | 930.56B |
| Glenmark Pharmaceuticals | 623.72B |
| Alkem Laboratories | 598.30B |
| Gland Pharma | 498.17B |
| Ipca Laboratories | 460.35B |
| Emcure Pharmaceuticals | 335.09B |